As of 2025-09-16, the Relative Valuation of Gossamer Bio Inc (GOSS) is (5.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.18 USD, the upside of Gossamer Bio Inc based on Relative Valuation is -279.2%.
The range of the Relative Valuation is (2.29) - (9.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.7x - 10.9x | 6.8x |
| Forward P/E multiples | 2.7x - 10.8x | 6.8x |
| Fair Price | (2.29) - (9.08) | (5.70) |
| Upside | -171.9% - -385.7% | -279.2% |
| Date | P/E |
| 2025-09-11 | -3.92 |
| 2025-09-10 | -3.70 |
| 2025-09-09 | -3.29 |
| 2025-09-08 | -3.16 |
| 2025-09-05 | -3.50 |
| 2025-09-04 | -2.98 |
| 2025-09-03 | -3.07 |
| 2025-09-02 | -3.08 |
| 2025-08-29 | -2.94 |
| 2025-08-28 | -2.85 |
| 2025-08-27 | -2.92 |
| 2025-08-26 | -3.01 |
| 2025-08-25 | -2.81 |
| 2025-08-22 | -2.78 |
| 2025-08-21 | -2.58 |
| 2025-08-20 | -2.32 |
| 2025-08-19 | -2.28 |
| 2025-08-18 | -2.37 |
| 2025-08-15 | -2.33 |
| 2025-08-14 | -2.33 |
| 2025-08-13 | -2.34 |
| 2025-08-12 | -2.29 |
| 2025-08-11 | -2.06 |
| 2025-08-08 | -2.09 |
| 2025-08-07 | -2.07 |
| 2025-08-06 | -2.35 |
| 2025-08-05 | -2.57 |
| 2025-08-04 | -2.58 |
| 2025-08-01 | -2.38 |
| 2025-07-31 | -2.43 |
| 2025-07-30 | -2.47 |
| 2025-07-29 | -2.33 |
| 2025-07-28 | -2.35 |
| 2025-07-25 | -2.19 |
| 2025-07-24 | -2.12 |
| 2025-07-23 | -2.22 |
| 2025-07-22 | -2.04 |
| 2025-07-21 | -2.08 |
| 2025-07-18 | -2.02 |
| 2025-07-17 | -2.03 |
| 2025-07-16 | -1.97 |
| 2025-07-15 | -1.72 |
| 2025-07-14 | -1.82 |
| 2025-07-11 | -1.62 |
| 2025-07-10 | -1.62 |
| 2025-07-09 | -1.62 |
| 2025-07-08 | -1.51 |
| 2025-07-07 | -1.49 |
| 2025-07-03 | -1.47 |
| 2025-07-02 | -1.44 |